You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dinaciclib

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer - Acute Myeloid Leukemia Trial in Australia, Spain, United States (Venetoclax, Dinaciclib)

Active, not recruiting
  • Cancer - Acute Myeloid Leukemia
  • Little Rock, Arkansas
  • +12 more
Dec 29, 2021

Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)

Active, not recruiting
Has Results
  • Acral Lentiginous Melanoma
  • +6 more
  • Dinaciclib
  • Mobile, Alabama
  • +190 more
Jan 28, 2023

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Houston (Dinaciclib, Epirubicin Hydrochloride,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Dinaciclib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 29, 2018

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Dinaciclib
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2018

Recurrent Plasma Cell Myeloma Trial in United States (Bortezomib, Dexamethasone, Dinaciclib)

Completed
  • Recurrent Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +5 more
May 10, 2018

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in Canada, United

Completed
  • Pancreatic Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • +3 more
  • Aurora, Colorado
  • +4 more
Aug 21, 2017

Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma Trial in Boston (dinaciclib, pharmacological study, laboratory

Terminated
Has Results
  • Stage IIIB Melanoma
  • +2 more
  • dinaciclib
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 3, 2017

Chronic Lymphocytic Leukemia (CLL) Trial (Dinaciclib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Feb 17, 2017

Refractory Multiple Myeloma Trial in Singapore, United States (dinaciclib, laboratory biomarker analysis)

Completed
Has Results
  • Refractory Multiple Myeloma
  • dinaciclib
  • laboratory biomarker analysis
  • Scottsdale, Arizona
  • +5 more
Jun 2, 2014